Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents

Jinn Rung Kuo, Yi Hsuan Cheng, Yi Shion Chen, Chung Ching Chio, Po-Wu Gean

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Traumatic brain injury (TBI) is the most common cause of death and acquired disability among children and young adults in the developed countries. In clinical studies, the incidence of depression is high after TBI, and the mechanisms behind TBI-induced depression remain unclear. In the present study, we subjected rats to a moderate fluid percussion into the closed cranial cavity to induce TBI. After 3 days of recovery, injured rats were given a forced swim test (FST) and novelty-suppressed feeding tests. We found that TBI rats exhibited increased duration of immobility and longer latency to begin chewing food in a new environment compared with sham-operated rats. Western blot analysis showed that TBI led to a decrease in the phosphorylated levels of extracellular signal regulated kinases (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK). Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), significantly reduced the duration of immobility when administered once per day for 14 days. Consistent with behavioral tests, fluoxetine treatment reversed TBI-induced decrease in p-ERK1/2 and p-p38 MAPK levels. Pre-treatment with a selective tryptophan hydroxylase inhibitor para-chlorophenylalanine (PCPA) blocked the antidepressant effect of fluoxetine. PCPA also prevented the effect of fluoxetine on ERK1/2 phosphorylation without affecting p38 MAPK phosphorylation. Pre-treatment with ERK inhibitor SL327 but not p38 MAPK inhibitor SB203580 prevented the antidepressant effect of fluoxetine. These results suggest that ERK1/2 plays a critical role in TBI-induced depression.

Original languageEnglish
Pages (from-to)1223-1231
Number of pages9
JournalJournal of Neurotrauma
Volume30
Issue number14
DOIs
Publication statusPublished - 2013 Jul 15

Fingerprint

Extracellular Signal-Regulated MAP Kinases
Rodentia
Fluoxetine
Depression
p38 Mitogen-Activated Protein Kinases
Fenclonine
Antidepressive Agents
Phosphorylation
Tryptophan Hydroxylase
Percussion
Traumatic Brain Injury
Mastication
Mitogen-Activated Protein Kinase 1
Serotonin Uptake Inhibitors
Protein Kinase Inhibitors
Developed Countries
Young Adult
Cause of Death
Therapeutics
Western Blotting

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Kuo, Jinn Rung ; Cheng, Yi Hsuan ; Chen, Yi Shion ; Chio, Chung Ching ; Gean, Po-Wu. / Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents. In: Journal of Neurotrauma. 2013 ; Vol. 30, No. 14. pp. 1223-1231.
@article{4ecf20f9e92447fdbc2b657f30fd7011,
title = "Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents",
abstract = "Traumatic brain injury (TBI) is the most common cause of death and acquired disability among children and young adults in the developed countries. In clinical studies, the incidence of depression is high after TBI, and the mechanisms behind TBI-induced depression remain unclear. In the present study, we subjected rats to a moderate fluid percussion into the closed cranial cavity to induce TBI. After 3 days of recovery, injured rats were given a forced swim test (FST) and novelty-suppressed feeding tests. We found that TBI rats exhibited increased duration of immobility and longer latency to begin chewing food in a new environment compared with sham-operated rats. Western blot analysis showed that TBI led to a decrease in the phosphorylated levels of extracellular signal regulated kinases (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK). Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), significantly reduced the duration of immobility when administered once per day for 14 days. Consistent with behavioral tests, fluoxetine treatment reversed TBI-induced decrease in p-ERK1/2 and p-p38 MAPK levels. Pre-treatment with a selective tryptophan hydroxylase inhibitor para-chlorophenylalanine (PCPA) blocked the antidepressant effect of fluoxetine. PCPA also prevented the effect of fluoxetine on ERK1/2 phosphorylation without affecting p38 MAPK phosphorylation. Pre-treatment with ERK inhibitor SL327 but not p38 MAPK inhibitor SB203580 prevented the antidepressant effect of fluoxetine. These results suggest that ERK1/2 plays a critical role in TBI-induced depression.",
author = "Kuo, {Jinn Rung} and Cheng, {Yi Hsuan} and Chen, {Yi Shion} and Chio, {Chung Ching} and Po-Wu Gean",
year = "2013",
month = "7",
day = "15",
doi = "10.1089/neu.2012.2689",
language = "English",
volume = "30",
pages = "1223--1231",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "14",

}

Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents. / Kuo, Jinn Rung; Cheng, Yi Hsuan; Chen, Yi Shion; Chio, Chung Ching; Gean, Po-Wu.

In: Journal of Neurotrauma, Vol. 30, No. 14, 15.07.2013, p. 1223-1231.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents

AU - Kuo, Jinn Rung

AU - Cheng, Yi Hsuan

AU - Chen, Yi Shion

AU - Chio, Chung Ching

AU - Gean, Po-Wu

PY - 2013/7/15

Y1 - 2013/7/15

N2 - Traumatic brain injury (TBI) is the most common cause of death and acquired disability among children and young adults in the developed countries. In clinical studies, the incidence of depression is high after TBI, and the mechanisms behind TBI-induced depression remain unclear. In the present study, we subjected rats to a moderate fluid percussion into the closed cranial cavity to induce TBI. After 3 days of recovery, injured rats were given a forced swim test (FST) and novelty-suppressed feeding tests. We found that TBI rats exhibited increased duration of immobility and longer latency to begin chewing food in a new environment compared with sham-operated rats. Western blot analysis showed that TBI led to a decrease in the phosphorylated levels of extracellular signal regulated kinases (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK). Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), significantly reduced the duration of immobility when administered once per day for 14 days. Consistent with behavioral tests, fluoxetine treatment reversed TBI-induced decrease in p-ERK1/2 and p-p38 MAPK levels. Pre-treatment with a selective tryptophan hydroxylase inhibitor para-chlorophenylalanine (PCPA) blocked the antidepressant effect of fluoxetine. PCPA also prevented the effect of fluoxetine on ERK1/2 phosphorylation without affecting p38 MAPK phosphorylation. Pre-treatment with ERK inhibitor SL327 but not p38 MAPK inhibitor SB203580 prevented the antidepressant effect of fluoxetine. These results suggest that ERK1/2 plays a critical role in TBI-induced depression.

AB - Traumatic brain injury (TBI) is the most common cause of death and acquired disability among children and young adults in the developed countries. In clinical studies, the incidence of depression is high after TBI, and the mechanisms behind TBI-induced depression remain unclear. In the present study, we subjected rats to a moderate fluid percussion into the closed cranial cavity to induce TBI. After 3 days of recovery, injured rats were given a forced swim test (FST) and novelty-suppressed feeding tests. We found that TBI rats exhibited increased duration of immobility and longer latency to begin chewing food in a new environment compared with sham-operated rats. Western blot analysis showed that TBI led to a decrease in the phosphorylated levels of extracellular signal regulated kinases (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK). Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), significantly reduced the duration of immobility when administered once per day for 14 days. Consistent with behavioral tests, fluoxetine treatment reversed TBI-induced decrease in p-ERK1/2 and p-p38 MAPK levels. Pre-treatment with a selective tryptophan hydroxylase inhibitor para-chlorophenylalanine (PCPA) blocked the antidepressant effect of fluoxetine. PCPA also prevented the effect of fluoxetine on ERK1/2 phosphorylation without affecting p38 MAPK phosphorylation. Pre-treatment with ERK inhibitor SL327 but not p38 MAPK inhibitor SB203580 prevented the antidepressant effect of fluoxetine. These results suggest that ERK1/2 plays a critical role in TBI-induced depression.

UR - http://www.scopus.com/inward/record.url?scp=84880354954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880354954&partnerID=8YFLogxK

U2 - 10.1089/neu.2012.2689

DO - 10.1089/neu.2012.2689

M3 - Article

VL - 30

SP - 1223

EP - 1231

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 14

ER -